iSpecimen IncISPC
Price$1.18

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value Insufficient data for a value estimatebased on filings through 31 Dec 2025
Market Price $1.18Price as of 30 Sep 2026
Data confidenceNot applicable

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 5.0% (near-term consensus, capped) · years 2–5: 5.0%/yr (balance of the path).5.0% per year
Years 6–10: glide to demonstrated growth own history 30.6%, capped at 20%
Per-year rates
Yr 65.0%Yr 75.0%Yr 85.0%Yr 95.0%Yr 105.0%
5.0% → 5.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 114.8%Yr 124.6%Yr 134.4%Yr 144.2%Yr 154.0%Yr 163.8%Yr 173.6%Yr 183.4%Yr 193.2%Yr 203.0%
5.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)30.6%
Discount rate (cost of equity) 11.3%
Volatility vs market (adjusted beta)1.42

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetiSpecimen IncISPCHealth Care
Valuation
P/E—
P/S1.8×
P/B0.6×
EV / Revenue0.4×
EV / EBITDA—
Profitability
Gross margin1.0%
Operating margin-465.3%
Net margin-543.5%
FCF margin-219.7%
Returns
ROE-339.7%
ROA-110.1%
ROIC—
Growth
Revenue growth (YoY)-79.2%
5-yr fwd EPS growth—
Financial strength
Debt / Equity0.00×
Current ratio—
Altman Z-Score—
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.